Head/Neck Neoplasm
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| IT or IA Infusion of PD1/PDL1/CTLA4 Inhibitors Versus IV for Immunotherapy of Head/Neck Cancers (HNC) (NCT03952065) | Second Affiliated Hospital of Guangzhou Medical University | 2019-01-01 |
Track Head/Neck Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.